Vesna Vranić Mandušić

Prof. Vesna Vranić Mandušić

University of Belgrade, Institute of Nuclear Sciences Vinca: Belgrade, RS
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAna Božović
Ana Božović
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
LTLidija Todorovic
Lidija Todorovic
MKMilena Krajnovic
Milena Krajnovic
The discovery of the Estrogen Receptor Beta (ERβ) in 1996 opened new perspectives in the diagnostics and therapy of different types of cancer. Here, we present a review of the present research knowledge about its role in endocrine-related cancers: breast, prostate, and thyroid, and colorectal cancers. We also discuss the reasons for the controversy of its role in carcinogenesis and why it is still not in use as a biomarker in clinical practice. Given that the diagnostics and therapy would benefit from the introduction of new biomarkers, we suggest ways to overcome the contradictions in elucidating the role of ERβ.

2 February 2014 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
NPNina Petrovic
Nina Petrovic
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
BSBoban Stanojevic
Boban Stanojevic
SLSilvana Lukić
Silvana Lukić
LTLidija Todorovic
Lidija Todorovic
BDBogomir Dimitrijević
Bogomir Dimitrijević

24 November 2010 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
ESEmina Sudar-Milovanovic
Emina Sudar-Milovanovic
BDBranislava Dobutovic
Branislava Dobutovic
SSSanja Soskic
Sanja Soskic
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
ZZZorica Zakula
Zorica Zakula
EIEsma Isenovic
Esma Isenovic

30 March 2016 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
NPNina Petrovic
Nina Petrovic
AKAna Kolakovic Perisa Ana Kolakovic
Ana Kolakovic Perisa Ana Kolakovic
ASAleksandra Stankovic
Aleksandra Stankovic
SLSilvana Lukić
Silvana Lukić
AŘAhmad Řami
Ahmad Řami
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
BACKGROUND: Breast carcinoma is heterogeneous disease. Understanding the process of invasion and metastasis and the selection of the therapy for patients with breast carcinomas still remains difficult. MicroRNAs are powerful gene expression regulator

23 December 2014 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
VBVladan Bajic
Vladan Bajic
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
ESElka Stefanova
Elka Stefanova
ABAna Božović
Ana Božović
RDRadoslav Davidovic
Radoslav Davidovic
BSBiljana Spremo-Potparevic
Biljana Spremo-Potparevic
X-chromosome instability has been a long established feature in Alzheimer's disease (AD). Premature centromere division and aneuploidy of the X-chromosome has been found in peripheral blood lymphocytes and neuronal tissue in female AD patients. Interestingly, only one chromosome of the X pair has been affected. These results raised a question, “Is the X-chromosome inactivation pattern altered in peripheral blood lymphocytes of women affected by AD?” To address this question, we analyzed the methylation status of androgen receptor promoter which may show us any deviation from the 50 : 50% X inactivation status in peripheral blood lymphocytes of women with AD. Our results showed skewed inactivation patterns (>90%). These findings suggest that an epigenetic alteration on the inactivation centers of the X-chromosome (or skewing) relates not only to aging, by might be a novel property that could account for the higher incidence of AD in women.

1 August 2012 in Cancer Letters
Verified
Journal Article
Closed access
VMVesna Vranić Mandušić
Vesna Vranić Mandušić
BDBogomir Dimitrijevic
Bogomir Dimitrijevic
DNDragica Nikolic-Vukosavljevic
Dragica Nikolic-Vukosavljevic
ZNZora Neskovic-Konstantinovic
Zora Neskovic-Konstantinovic
KKKsenija Kanjer
Ksenija Kanjer
UHUte Hamann
Ute Hamann